Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)

June 28, 2024

https://www.globenewswire.com/news-release/2024/06/28/2906030/0/en/Dianthus-Therapeutics-Announces-Two-Poster-Presentations-for-DNTH103-at-the-10th-Congress-of-the-European-Academy-of-Neurology-EAN.html

NEW YORK and WALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq:DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced two poster presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN), taking place June 29-July 2, 2024 in Helsinki.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.